| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |